Educational Grant Supporters

Oncology Clinical Pathways Congress would like to thank the following companies for their independent support of our 2021 program and their ongoing commitment to healthcare education.

 

AstraZeneca

Daiichi Sankyo

Eisai, Inc.

GlaxoSmithKline

Janssen Biotech, Inc.

Merck Sharp & Dohme Corp.

Novartis Pharmaceuticals Corporation

NOVOCURE

Sanofi Genzyme

Seattle Genetics

Takeda Oncology